AstraZeneca
AZN
$70.85
Share price
1.03%
Change (1 day)
-6.54%
Change (1 year)
Categories
EPS for AstraZeneca (AZN)
EPS in 2023 (TTM): $1.98
According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $1.98. In 2022 the company made an earnings per share (EPS) of $1.06 an increase over its 2021 EPS that were of $0.14.
EPS history for AstraZeneca from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.98 | 87.26% |
| 2022 | $1.06 | 631.03% |
| 2021 | $0.14 | -88.11% |
| 2020 | $1.22 | 136.89% |
| 2019 | $0.51 | -39.41% |
| 2018 | $0.85 | -28.27% |
| 2017 | $1.18 | -14.37% |
| 2016 | $1.38 | 24.11% |
| 2015 | $1.12 | 127.55% |
| 2014 | $0.49 | -51.96% |
| 2013 | $1.02 | -58.95% |
| 2012 | $2.48 | -32.2% |
| 2011 | $3.66 | 30.89% |
| 2010 | $2.80 | 7.9% |
| 2009 | $2.60 | 23.57% |
| 2008 | $2.10 | 12.3% |
| 2007 | $1.87 | -3.11% |
| 2006 | $1.93 | 32.65% |
| 2005 | $1.45 | -94.03% |
| 2004 | $24.35 | 2651.98% |
| 2003 | $0.89 | 7.93% |
| 2002 | $0.82 | 1.32% |
| 2001 | $0.81 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 609.59% | 🇺🇸 USA |
 Novartis NVS | $3.74 | 88.41% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -6.30% | 🇺🇸 USA |
 Abbott Laboratories ABT | $2.97 | 49.73% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 173.52% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | 60.21% | 🇫🇷 France |
 Biogen BIIB | $18.46 | 829.97% | 🇺🇸 USA |
 Merck MRK | $1.82 | -8.23% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | 100.00% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | 76.36% | 🇬🇧 UK |